Vermali Rodriguez's Colleagues at QED Therapeutics
Vermali Rodriguez's Contact Details
HQ
650-231-4088
650-231-4088
Location
Miami/Fort Lauderdale Area
Miami/Fort Lauderdale Area
Company
QED Therapeutics
QED Therapeutics
Vermali Rodriguez's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Vermali Rodriguez
Vermali Rodriguez currently works for QED Therapeutics.
Vermali Rodriguez's role at QED Therapeutics is Medical Science Liaison.
Vermali Rodriguez's email address is ***@qedtx.com. To view Vermali Rodriguez's full email address, please signup to ConnectPlex.
Vermali Rodriguez works in the BioTech/Drugs industry.
Vermali Rodriguez's colleagues at QED Therapeutics are Kathleen Guindon, Brian Boyles, Richard Jones II, Edward Oliva, Sudesh PhD, Quoc M., Ai Li and others.
Vermali Rodriguez's phone number is 650-231-4088